Human colostrum contains IgA antibodies reactive to colonization factors I and II of enterotoxigenic Escherichia coli
- PMID: 16831206
- DOI: 10.1111/j.1574-695X.2006.00082.x
Human colostrum contains IgA antibodies reactive to colonization factors I and II of enterotoxigenic Escherichia coli
Abstract
Diarrhea is an important cause of morbidity and mortality amongst infants of low socio-economic levels in developing countries and in travelers who visit such areas. Enterotoxigenic E. coli strains express two sets of virulence-associated factors: enterotoxins (heat-stable toxins or heat-labile toxins) and colonization factors. Studies have shown that breast-feeding protects infants against infectious diseases, such as diarrhea, as it presents a great variety of immunological components. The aim of this study was to analyze the reactivity of immunoglobulin A from human colostrum to colonization factor antigens I and II. The colostrum ability in preventing enterotoxigenic E. coli adhesion to Caco-2 cells was also evaluated. Colostrum samples were collected from 32 healthy women, and a human colostrum pool was prepared. Enterotoxigenic E. coli strains expressing colonization factor antigens I and II were utilized. The colostrum pool and individual samples showed variable antienterotoxigenic E. coli immunoglobulin A titers, that were reactive with colonization factor antigen I and CS1/CS3 (colonization factor antigen II). The human colostrum pool and individual samples inhibited enterotoxigenic E. coli colonization factor antigen I and II adhesion to Caco-2 cells, at variable levels, and this ability was a result of immunoglobulin A antibodies reactive to these colonization factors. The immunoglobulin A-depleted pool lost this inhibitory ability. As bacterial adhesion is the initial mechanism of enterotoxigenic E. coli infection, breast-feeding could protect the offspring against diarrhea caused by this agent.
Similar articles
-
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.N Engl J Med. 1988 May 12;318(19):1240-3. doi: 10.1056/NEJM198805123181904. N Engl J Med. 1988. PMID: 3283555 Clinical Trial.
-
Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.Infect Immun. 2006 Feb;74(2):1062-71. doi: 10.1128/IAI.74.2.1062-1071.2006. Infect Immun. 2006. PMID: 16428753 Free PMC article. Clinical Trial.
-
Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.Gastroenterology. 1984 Oct;87(4):934-40. Gastroenterology. 1984. PMID: 6381216
-
Vaccines for enterotoxigenic Escherichia coli: current status.Curr Opin Gastroenterol. 2005 Jan;21(1):15-9. Curr Opin Gastroenterol. 2005. PMID: 15687879 Review.
-
[Colonization factors in enterotoxigenic Escherichia coli].Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1985 Apr-Jun;30(2):115-30. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol. 1985. PMID: 2865802 Review. Romanian. No abstract available.
Cited by
-
Breast milk delivery of an engineered dimeric IgA protects neonates against rotavirus.Mucosal Immunol. 2025 Apr;18(2):441-452. doi: 10.1016/j.mucimm.2025.01.002. Epub 2025 Jan 20. Mucosal Immunol. 2025. PMID: 39842610 Free PMC article.
-
Diarrhea burden due to natural infection with enterotoxigenic Escherichia coli in a birth cohort in a rural Egyptian community.J Clin Microbiol. 2014 Jul;52(7):2595-603. doi: 10.1128/JCM.00215-14. Epub 2014 May 14. J Clin Microbiol. 2014. PMID: 24829232 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous